What is CJC-1295?
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the natural production of growth hormone from the pituitary gland. With a half-life of 6-8 days, it provides sustained growth hormone elevation leading to enhanced muscle growth, fat loss, improved recovery, and anti-aging benefits.
GHRH Analog
CJC-1295 is designed to mimic natural growth hormone-releasing hormone (GHRH) with an extended half-life.
Pituitary Signal
It sends sustained signals to the pituitary gland to naturally increase growth hormone production and IGF-1 levels.
Research and Potential Benefits
CJC-1295 significantly enhances muscle protein synthesis and recovery through sustained growth hormone elevation.
- ✓ Increases Muscle Mass: Stimulates protein synthesis leading to lean muscle growth and strength gains.
- ✓ Faster Recovery: Accelerates tissue repair and reduces recovery time between workouts.
- ✓ Increased IGF-1: Elevates IGF-1 levels by up to 80% for enhanced anabolic effects.
CJC-1295 promotes fat loss and provides anti-aging benefits through sustained growth hormone elevation.
- ✓ Reduces Body Fat: Promotes lipolysis leading to significant reductions in body fat percentage.
- ✓ Improves Skin Quality: Increases collagen production for better skin elasticity and reduced wrinkles.
- ✓ Enhanced Sleep: Improves sleep quality and promotes deeper, more restorative sleep cycles.
As a research peptide, CJC-1295 has been studied in clinical trials with a relatively favorable safety profile, but requires medical supervision.
- ! Research Use Only: Not FDA-approved for human use; available only through compounding pharmacies for research purposes.
- ! Common Side Effects: Injection site reactions, headache, flushing, and transient increases in heart rate.
- ! Contraindications: Avoid in patients with active cancer, severe heart disease, or hypersensitivity to growth hormone.
References & Citations
- Teichman, S. L., et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab.
- Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab.
Ask Dr. John About CJC-1295
Get personalized clinical insights from Dr. Jobby John, PharmD, FACA. Ask specific questions about CJC-1295 and receive evidence-based answers from his extensive clinical experience.